The relevance of "non-criteria" clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features

Mirhelen M. Abreu, Adriana Danowski, Denis G. Wahl, Mary Carmen Amigo, Maria Tektonidou, Marcelo S. Pacheco, Norma Fleming, Vinicius Domingues, Savino Sciascia, Julia O. Lyra, Michelle Petri, Munther Khamashta, Roger A. Levy

Research output: Contribution to journalArticle

Abstract

The purpose of this task force was to critically analyze nine non-criteria manifestations of APS to support their inclusion as APS classification criteria. The Task Force Members selected the non-criteria clinical manifestations according to their clinical relevance, that is, the patient-important outcome from clinician perspective. They included superficial vein thrombosis, thrombocytopenia, renal microangiopathy, heart valve disease, livedo reticularis, migraine, chorea, seizures and myelitis, which were reviewed by this International Task Force collaboration, in addition to the seronegative APS (SN-APS). GRADE system was used to evaluate the quality of evidence of medical literature of each selected item. This critical appraisal exercise aimed to support the debate regarding the clinical picture of APS. We found that the overall GRADE analysis was very low for migraine and seizures, low for superficial venous thrombosis, thrombocytopenia, chorea, longitudinal myelitis and the so-called seronegative APS and moderate for APS nephropathy, heart valve lesions and livedo reticularis. The next step can be a critical redefinition of an APS gold standard, for instance derived from the APS ACTION registry that will include not only current APS patients but also those with antiphospholipid antibodies not meeting current classification criteria.

Original languageEnglish (US)
Pages (from-to)401-414
Number of pages14
JournalAutoimmunity Reviews
Volume14
Issue number5
DOIs
StatePublished - May 1 2015

Fingerprint

Antiphospholipid Antibodies
Antiphospholipid Syndrome
Advisory Committees
Livedo Reticularis
Myelitis
Chorea
Migraine Disorders
Thrombocytopenia
Seizures
Heart Valve Diseases
Heart Valves
Venous Thrombosis
Registries
Veins
Thrombosis
Exercise
Kidney

Keywords

  • Accuracy
  • Antiphospholipid Syndrome
  • Clinical features
  • GRADE system
  • Non-criteria manifestations

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Medicine(all)

Cite this

The relevance of "non-criteria" clinical manifestations of antiphospholipid syndrome : 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features. / Abreu, Mirhelen M.; Danowski, Adriana; Wahl, Denis G.; Amigo, Mary Carmen; Tektonidou, Maria; Pacheco, Marcelo S.; Fleming, Norma; Domingues, Vinicius; Sciascia, Savino; Lyra, Julia O.; Petri, Michelle; Khamashta, Munther; Levy, Roger A.

In: Autoimmunity Reviews, Vol. 14, No. 5, 01.05.2015, p. 401-414.

Research output: Contribution to journalArticle

Abreu, Mirhelen M. ; Danowski, Adriana ; Wahl, Denis G. ; Amigo, Mary Carmen ; Tektonidou, Maria ; Pacheco, Marcelo S. ; Fleming, Norma ; Domingues, Vinicius ; Sciascia, Savino ; Lyra, Julia O. ; Petri, Michelle ; Khamashta, Munther ; Levy, Roger A. / The relevance of "non-criteria" clinical manifestations of antiphospholipid syndrome : 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features. In: Autoimmunity Reviews. 2015 ; Vol. 14, No. 5. pp. 401-414.
@article{3c277041d4be43a090685d4734e830b6,
title = "The relevance of {"}non-criteria{"} clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features",
abstract = "The purpose of this task force was to critically analyze nine non-criteria manifestations of APS to support their inclusion as APS classification criteria. The Task Force Members selected the non-criteria clinical manifestations according to their clinical relevance, that is, the patient-important outcome from clinician perspective. They included superficial vein thrombosis, thrombocytopenia, renal microangiopathy, heart valve disease, livedo reticularis, migraine, chorea, seizures and myelitis, which were reviewed by this International Task Force collaboration, in addition to the seronegative APS (SN-APS). GRADE system was used to evaluate the quality of evidence of medical literature of each selected item. This critical appraisal exercise aimed to support the debate regarding the clinical picture of APS. We found that the overall GRADE analysis was very low for migraine and seizures, low for superficial venous thrombosis, thrombocytopenia, chorea, longitudinal myelitis and the so-called seronegative APS and moderate for APS nephropathy, heart valve lesions and livedo reticularis. The next step can be a critical redefinition of an APS gold standard, for instance derived from the APS ACTION registry that will include not only current APS patients but also those with antiphospholipid antibodies not meeting current classification criteria.",
keywords = "Accuracy, Antiphospholipid Syndrome, Clinical features, GRADE system, Non-criteria manifestations",
author = "Abreu, {Mirhelen M.} and Adriana Danowski and Wahl, {Denis G.} and Amigo, {Mary Carmen} and Maria Tektonidou and Pacheco, {Marcelo S.} and Norma Fleming and Vinicius Domingues and Savino Sciascia and Lyra, {Julia O.} and Michelle Petri and Munther Khamashta and Levy, {Roger A.}",
year = "2015",
month = "5",
day = "1",
doi = "10.1016/j.autrev.2015.01.002",
language = "English (US)",
volume = "14",
pages = "401--414",
journal = "Autoimmunity Reviews",
issn = "1568-9972",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - The relevance of "non-criteria" clinical manifestations of antiphospholipid syndrome

T2 - 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features

AU - Abreu, Mirhelen M.

AU - Danowski, Adriana

AU - Wahl, Denis G.

AU - Amigo, Mary Carmen

AU - Tektonidou, Maria

AU - Pacheco, Marcelo S.

AU - Fleming, Norma

AU - Domingues, Vinicius

AU - Sciascia, Savino

AU - Lyra, Julia O.

AU - Petri, Michelle

AU - Khamashta, Munther

AU - Levy, Roger A.

PY - 2015/5/1

Y1 - 2015/5/1

N2 - The purpose of this task force was to critically analyze nine non-criteria manifestations of APS to support their inclusion as APS classification criteria. The Task Force Members selected the non-criteria clinical manifestations according to their clinical relevance, that is, the patient-important outcome from clinician perspective. They included superficial vein thrombosis, thrombocytopenia, renal microangiopathy, heart valve disease, livedo reticularis, migraine, chorea, seizures and myelitis, which were reviewed by this International Task Force collaboration, in addition to the seronegative APS (SN-APS). GRADE system was used to evaluate the quality of evidence of medical literature of each selected item. This critical appraisal exercise aimed to support the debate regarding the clinical picture of APS. We found that the overall GRADE analysis was very low for migraine and seizures, low for superficial venous thrombosis, thrombocytopenia, chorea, longitudinal myelitis and the so-called seronegative APS and moderate for APS nephropathy, heart valve lesions and livedo reticularis. The next step can be a critical redefinition of an APS gold standard, for instance derived from the APS ACTION registry that will include not only current APS patients but also those with antiphospholipid antibodies not meeting current classification criteria.

AB - The purpose of this task force was to critically analyze nine non-criteria manifestations of APS to support their inclusion as APS classification criteria. The Task Force Members selected the non-criteria clinical manifestations according to their clinical relevance, that is, the patient-important outcome from clinician perspective. They included superficial vein thrombosis, thrombocytopenia, renal microangiopathy, heart valve disease, livedo reticularis, migraine, chorea, seizures and myelitis, which were reviewed by this International Task Force collaboration, in addition to the seronegative APS (SN-APS). GRADE system was used to evaluate the quality of evidence of medical literature of each selected item. This critical appraisal exercise aimed to support the debate regarding the clinical picture of APS. We found that the overall GRADE analysis was very low for migraine and seizures, low for superficial venous thrombosis, thrombocytopenia, chorea, longitudinal myelitis and the so-called seronegative APS and moderate for APS nephropathy, heart valve lesions and livedo reticularis. The next step can be a critical redefinition of an APS gold standard, for instance derived from the APS ACTION registry that will include not only current APS patients but also those with antiphospholipid antibodies not meeting current classification criteria.

KW - Accuracy

KW - Antiphospholipid Syndrome

KW - Clinical features

KW - GRADE system

KW - Non-criteria manifestations

UR - http://www.scopus.com/inward/record.url?scp=84925141086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925141086&partnerID=8YFLogxK

U2 - 10.1016/j.autrev.2015.01.002

DO - 10.1016/j.autrev.2015.01.002

M3 - Article

C2 - 25641203

AN - SCOPUS:84925141086

VL - 14

SP - 401

EP - 414

JO - Autoimmunity Reviews

JF - Autoimmunity Reviews

SN - 1568-9972

IS - 5

ER -